Chemtrade Q2 FY26 adjusted EBITDA falls 7.8% to $127.3 million; revenue rises 16.5% to $578.7 million

• Chemtrade reported Q2 2026 net earnings of $42.9 million, up from $9.7 million a year earlier, on lower finance costs.
• Revenue rose 16.5% year over year to $578.7 million, driven by the Polytec acquisition plus higher prices for merchant acid.
• Adjusted EBITDA fell 7.8% to $127.3 million, reflecting a roughly $7 million hit from the North Vancouver maintenance turnaround.
• Distributable cash after maintenance capital expenditures dropped 40.7% to $42.4 million; payout ratio was 47%.
• 2026 adjusted EBITDA guidance reiterated at $485 million-$525 million amid input and product price volatility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemtrade Logistics Income Fund published the original content used to generate this news brief via Business Wire (Ref. ID: 202608121800BIZWIRE_USPR_____20260812_BW474991) on August 12, 2026, and is solely responsible for the information contained therein.